Clinical Research News
-
SillaJen to discontinue PHOCUS trial for advanced liver cancer
Clinical Research | News | 0 Comment | 06 Aug, 2019
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, has announced that the Independent Dat...Read more
-
"Improving trial efficiency and lowering trial costs is a big challenge"
Clinical Research | Opinion | 0 Comment | 05 Aug, 2019
Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can used to replace patients in clinical trials. A key priority for the l...Read more
-
Botanix receives commitments for A$40M in US-led institutional placement
Clinical Research | News | 0 Comment | 05 Aug, 2019
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm commitments in respect of a A$40m placement led by specialist US-based b...Read more
-
Veristat expands operations into Taiwan
Clinical Research | News | 0 Comment | 01 Aug, 2019
US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces the formal launch of its Clinical Trial, Biostatistics and Programmin...Read more
-
CStone to initiate ivosidenib Phase I study in China
Clinical Research | News | 0 Comment | 22 Jul, 2019
CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the t...Read more
-
Kazia to use drug with radiotherapy for brain cancer treatment
Clinical Research | News | 0 Comment | 23 Jul, 2019
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) in New York, NY will inv...Read more
-
SOTIO initiates first-in-human clinical trial with IL-15 superagonist SO-C101
Clinical Research | News | 0 Comment | 12 Jul, 2019
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with SO-C101, a superagonist fusion protein of interleukin IL-15. The pha...Read more
-
CStone announces first patient dosed in China with avapritinib for advanced GIST
Clinical Research | News | 0 Comment | 10 Jul, 2019
CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in China with avapritinib in the ongoing global Phase III VOYAGER cli...Read more
-
Clinical Research | News | 0 Comment | 08 Jul, 2019
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe ...Read more
-
Takeda announces results from Phase IIIb/IV clinical trial for ADYNOVATE
Clinical Research | News | 0 Comment | 08 Jul, 2019
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced updated results from its phase IIIb/IV clinical trial for ADYNOVATE&nbs...Read more
-
Sommetrics completes study of new sleep apnea treatment in ethnic Japanese subjects
Clinical Research | News | 0 Comment | 26 Jun, 2019
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has announced the completion of clinical study SOM-014. This trial evaluated t...Read more
-
FDA Grants Orphan Drug Designation to XWL-008 to treat Narcolepsy
Clinical Research | News | 0 Comment | 25 Jun, 2019
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel small molecule therapeutics for the treatment of neurological disorder...Read more
-
Prestige Biopharma reports Ph III results for Tuznue
Clinical Research | News | 0 Comment | 24 Jun, 2019
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluating the efficacy, safety, and pharmacokinetics (PK) of biosimilar cand...Read more
-
Parexel launches an enhanced integrated outsourcing delivery model for FSP
Clinical Research | News | 0 Comment | 24 Jun, 2019
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization...Read more
-
Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial
Clinical Research | News | 0 Comment | 24 Jun, 2019
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumours and related diseases, on 24 June 20...Read more
-
FasT CAR-19 Therapy Shows Positive Impact in Patients with (r/r) B-ALL
Clinical Research | News | 0 Comment | 21 Jun, 2019
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announced preliminary results of a multi-centre pilot study d...Read more
-
Edesa Biotech receives approval to proceed with its clinical investigation
Clinical Research | News | 0 Comment | 20 Jun, 2019
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration has notified the company that it may proceed with its clinical investi...Read more
-
BI, Lilly announces results of new post-hoc analysis of data from the EMPA-REG OUTCOME trial
Clinical Research | News | 0 Comment | 17 Jun, 2019
Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-REG OUTCOME trial. These results indicated that the effect of empaglif...Read more
